News & Updates

Show Multimedia Only

Circulating T cells tied to CVD risk in people with HIV infection

20 Oct 2022 by

Subsets of peripheral circulating CD4 T cell among people with HIV infection (PWH) are predictive of incident cardiovascular disease (CVD), including heart failure and atherosclerotic CVD, reveals a study.

20 Oct 2022

Vitamin C may play protective role in metabolic disorders among overweight patients

20 Oct 2022

Vitamin C appears to protect against metabolic disorders due to its close association with glucose-lipid metabolism in overweight and obese patients who are undergoing laparoscopic sleeve gastrectomy (LSG), according to a study. Moreover, LSG does not seem to worsen the vitamin C status or deficiency.

20 Oct 2022

Beta-blocker shows potential for diabetic foot ulcers

20 Oct 2022 by

A novel, topical formulation of esmolol, a cardio-selective beta-1 adrenergic blocker, may just have landed a spot in the diabetes treatment landscape, as it shows promise as treatment alternative for diabetic foot ulcers (DFUs).

20 Oct 2022

Smartphones measure physical performance after lumbar spine surgery

20 Oct 2022 by

Smartphone-based real-life activity data can be used to track physical performance in patients after lumbar spine surgery for degenerative lumbar disorders (DLD), according to a recent study.

20 Oct 2022

Smoking during pregnancy ups hypertension risk in offspring

20 Oct 2022

Children exposed to maternal smoking during pregnancy have higher systolic blood pressure (SBP) and are at a heightened risk of hypertension, a recent study has found.

20 Oct 2022

Vitamin D deficiency tied to death risk in diabetic foot ulcer

20 Oct 2022

In patients with diabetic foot ulcers (DFU), vitamin D deficiency appears to aggravate the risk of all-cause mortality, reports a recent China study.

20 Oct 2022

Fish oil lipid emulsion of little neurodevelopmental benefit in ELBW infants

20 Oct 2022

In infants born with extremely low birth weight (ELBW), parenteral nutrition supplement using a mixed lipid emulsion containing fish oil does not result in neurodevelopmental or behavioural benefits at preschool age, a new study has found.

20 Oct 2022

Pembrolizumab improves DFS in completely resected stage IB–IIIA NSCLC

20 Oct 2022 by

Adjuvant pembrolizumab significantly improves disease-free survival (DFS) vs placebo in patients with completely resected, PD-L1–unselected, stage IB–IIIA non-small-cell lung cancer (NSCLC), a second interim analysis of the triple-blind phase III PEARLS/KEYNOTE-091 trial has shown.

20 Oct 2022

Dupilumab reduces itch, improves skin lesions in prurigo nodularis

20 Oct 2022 by

Dupilumab improves itch response and skin lesions in patients with prurigo nodularis (PN) inadequately controlled with prior therapies in the LIBERTY-PN PRIME trial.

20 Oct 2022

Add-on ozoralizumab safe, effective in rheumatoid arthritis

19 Oct 2022

Ozoralizumab, when used in combination with methotrexate (MTX), appears to yield significant reductions in the signs and symptoms of rheumatoid arthritis (RA) while having an acceptable tolerability, according to data from a double-blind, parallel-group, placebo-controlled phase II/III trial.

19 Oct 2022

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Circulating T cells tied to CVD risk in people with HIV infection

Vitamin C may play protective role in metabolic disorders among overweight patients

Beta-blocker shows potential for diabetic foot ulcers

Smartphones measure physical performance after lumbar spine surgery

Smoking during pregnancy ups hypertension risk in offspring

Vitamin D deficiency tied to death risk in diabetic foot ulcer

Fish oil lipid emulsion of little neurodevelopmental benefit in ELBW infants

Pembrolizumab improves DFS in completely resected stage IB–IIIA NSCLC

Dupilumab reduces itch, improves skin lesions in prurigo nodularis

Add-on ozoralizumab safe, effective in rheumatoid arthritis